Press Releases

PharmaCyte Biotech’s Pancreatic Cancer Treatment Named as Near-Term Approach to Rising Pancreatic Cancer Rates

SILVER SPRING, MD, January 15, 2014 (GLOBE NEWSWIRE) – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live cell encapsulation technology, Cell-in-a-Box®, today announced that well-known scientific journalist, Vicki Brower, who writes for the leading top-tier cancer journals, has published an